Eosinophil as a cellular target of the ocular anti-allergic action of mapracorat, a novel selective glucocorticoid receptor agonist

Molecular Vision

Volumn 17, Issue , 2011, Pages 3208-3223

  Baiula, Monica ^a   Spartà, Antonino ^a   Bedini, Andrea ^a   Carbonari, Gioia ^a   Bucolo, Claudio ^b   Ward, Keith W ^c   Zhang, Jin Zhong ^c   Govoni, Paolo ^d   Spampinato, Santi ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c BAUSCH AND LOMB   (United States)

^d UNIVERSITY OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BOL 303242 X; CHEMOKINE RECEPTOR CXCR4; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; LIPOCORTIN 1; MAPRACORAT; MIFEPRISTONE; RANTES; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZK 245186;

ALLERGIC CONJUNCTIVITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIALLERGIC ACTIVITY; APOPTOSIS; ARTICLE; CELL MIGRATION; CELL SURVIVAL; CONJUNCTIVA; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG ACTIVITY; DRUG EFFICACY; DRUG POTENCY; DRUG TARGETING; EOSINOPHIL; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MAST CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADMINISTRATION, OPHTHALMIC; ANIMALS; ANNEXIN A1; ANTI-ALLERGIC AGENTS; APOPTOSIS; BENZOFURANS; BLOTTING, WESTERN; CASPASE 3; CELLS, CULTURED; CONJUNCTIVA; CONJUNCTIVITIS, ALLERGIC; CYTOKINES; DEXAMETHASONE; EOSINOPHILS; FLOW CYTOMETRY; GUINEA PIGS; HUMANS; MALE; MIFEPRISTONE; OPHTHALMIC SOLUTIONS; OVALBUMIN; PENTANOLS; QUINOLINES; RECEPTORS, GLUCOCORTICOID;

EID: 84862934152     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Leonardi A, Motterle L, Bortolotti M. Allergy and the eye. Clin Exp Immunol 2008; 153:17-21. [PMID: 18721324]
2. Miyazaki D, Tominaga T, Yakura K, Kuo CH, Komatsu N, Inoue Y, Ono SJ. Conjunctival mast cell as a mediator of eosinophilic response in ocular allergy. Mol Vis 2008; 14:1525-32. [PMID: 18728750]
3. Ono SJ, Abelson MB. Allergic conjunctivitis: update on pathophysiology and prospects for future treatment. J Allergy Clin Immunol 2005; 115:118-22. [PMID: 15637556]
4. Druilhe A, Letuve S, Pretolani M. Glucocorticoid-induced apoptosis in human eosinophils: mechanisms of action. Apoptosis 2003; 8:481-95. [PMID: 12975579]
5. Frauman AG. An overview of the adverse reactions to adrenal corticosteroids. Adverse Drug React Toxicol Rev 1996; 15:203-6. [PMID: 9113247]
6. Carnahan MC, Goldstein DA. Ocular complications of topical, peri-ocular, and systemic corticosteroids. Curr Opin Ophthalmol 2000; 11:478-83. [PMID: 11141645]
7. Biddie SC, Hager GL. Glucocorticoid receptor dynamics and gene regulation. Stress 2009; 12:193-205. [PMID: 19051126]
8. Catley M. Dissociated steroids. ScientificWorldJournal 2007; 7:421-30. [PMID: 17450306]
9. Zhang JZ, Cavet ME, VanderMeid KR, Salvador-Silva M, Lopez FJ, Ward KW. BOL-303242-X, a novel selective glucocorticoid receptor agonist, with full anti-inflammatory properties in human ocular cells. Mol Vis 2009; 15:2606-16. [PMID: 20011631]
10. De Bosscher K, Haegeman G. Minireview: latest perspectives on antiinflammatory actions of glucocorticoids. Mol Endocrinol 2009; 23:281-91. [PMID: 19095768]
11. Clark AR. Anti-inflammatory functions of glucocorticoidinduced genes. Mol Cell Endocrinol 2007; 275:79-97. [PMID: 17561338]
12. Schäcke H, Döcke WD, Asadullah K. Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther 2002; 96:23-43. [PMID: 12441176]
13. McMaster A. Ray DW Drug insight: selective agonists and antagonists of the glucocorticoid receptor. Nat Clin Pract Endocrinol Metab 2008; 4:91-101. [PMID: 18212811]
14. Newton R, Holden NS. Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor? Mol Pharmacol 2007; 72:799-809. [PMID: 17622575]
15. Schäcke H, Zollner TM, Docke WD, Rehwinkel H, Jaroch S, Skuballa W, Neuhaus R, May E, Zügel U, Asadullah K. Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases. Br J Pharmacol 2009; 158:1088-103. [PMID: 19422381]
16. Shafiee A, Bucolo C, Budzynski E, Ward KW, Lopez FJ. In vivo ocular efficacy profile of BOL-303242-X, a novel selective glucocorticoid receptor agonist, in rabbit models of ocular disease. Invest Ophthalmol Vis Sci 2011; 52:1422-30. [PMID: 20881303]
17. Pfeffer BA, DeWitt CA, Salvador-Silva M, Cavet ME, Lopez FJ, Ward KW. Reduced myocilin expression in cultured monkey trabecular meshwork cells induced by a selective glucocorticoid receptor agonist: comparison with steroids. Invest Ophthalmol Vis Sci 2010; 51:437-46. [PMID: 19696178]
18. Sohn S, Hur W, Cho YR, Chung YS, Ki C-S, Kee C. Little evidence for association of the glaucoma gene MYOC with open-angle glaucoma. Br J Ophthalmol 2010; 94:639-42. [PMID: 20447966]
19. Cavet ME, Harrington KL, Ward KW, Zhang J-Z. Mapracorat, a novel selective glucocorticoid receptor agonist, inhibits hyperosmolar-induced cytokine release and MAPK pathways in human corneal epithelial cells. Mol Vis 2010; 16:1791-800. [PMID: 20824100]
20. Nilsson G, Blom T, Kusche-Gullberg M, Kjellen L, Butterfield JH, Sundstrom C, Nilsson K, Hellman L. Phenotypic characterization of the human mast-cell line HMC-1. Scand J Immunol 1994; 39:489-98. [PMID: 8191224]
21. Kankaanranta H, Janka-Junttila M, Ilmarinen-Salo P, Ito K, Jalonen U, Ito M, Adcock IM, Moilanen E, Zhang X. Histone deacetylase inhibitors induce apoptosis in human eosinophils and neutrophils. J Inflamm (Lond) 2010; 7:9. [PMID: 20181093]
22. Janka-Junttila M, Moilanen E, Hasala H, Zhang X, Adcock I, Kankaanranta H. The glucocorticoid RU24858 does not distinguish between transrepression and transactivation in primary human eosinophils. J Inflamm (Lond) 2006; 3:10. [PMID: 16834783]
23. Létuvé S, Druilhe A, Grandsaigne M, Aubier M, Pretolani M. Critical role of mitochondria, but not caspases, during glucocorticosteroid-induced human eosinophil apoptosis. Am J Respir Cell Mol Biol 2002; 26:565-71. [PMID: 11970908]
24. Qasem AR, Bucolo C, Baiula M, Sparta A, Govoni P, Bedini A, Fascì D, Spampinato S. Contribution of alpha4beta1 integrin to the antiallergic effect of levocabastine. Biochem Pharmacol 2008; 76:751-62. [PMID: 18680729]
25. Luna LG. Manual of histologic staining methods of the Armed Forces Institute of Pathology. Third Edition. New York: Mc Graw Hill Co.; 1968. p. 111-2.
26. Zhang X, Moilanen E, Kankaanranta H. Enhancement of human eosinophil apoptosis by fluticasone propionate, budesonide, and beclomethasone. Eur J Pharmacol 2000; 406:325-32. [PMID: 11040338]
27. Hagan JB, Kita H, Gleich GJ. Inhibition of interleukin-5 mediated eosinophil viability by fluticasone 17-propionate: comparison with other glucocorticoids. Clin Exp Allergy 1998; 28:999-1006. [PMID: 9756205]
28. Cheng G, Ueda T, Nakajima H, Nakajima A, Kinjyo S, Motojima S, Kukuda T. Suppressive effects of SP-A on ionomycin-induced IL-8 production and release by eosinophils. Int Arch Allergy Immunol 1998; 117:59-62. [PMID: 9758900]
29. Park HS, Jung KS, Shute J, Roberts K, Holgate ST, Djukanovic R. Allergen-induced release of GM-CSF and IL-8 in vitro by nasal polyp tissue from atopic subjects prolongs eosinophil survival. Eur Respir J 1997; 10:1476-82. [PMID: 9230233]
30. Chauhan S, Leach CH, Kunz S, Bloom JW, Miesfeld RL. Glucocorticoid regulation of human eosinophil gene expression. J Steroid Biochem Mol Biol 2003; 84:441-52. [PMID: 12732289]
31. McColl A, Michlewska S, Dransfield I, Rossi AG. Effects of glucocorticoids on apoptosis and clearance of apoptotic cells. ScientificWorldJournal 2007; 7:1165-81. [PMID: 17704849]
32. Sugimoto Y, Ogawa M, Tai N, Kamei C. Inhibitory effects of glucocorticoids on rat eosinophil superoxide generation and chemotaxis. Int Immunopharmacol 2003; 3:845-52. [PMID: 12781701]
33. Uller L, Lloyd CM, Rydell-Törmänen K, Persson CG, Erjefält JS. Effects of steroid treatment on lung CC chemokines, apoptosis and transepithelial cell clearance during development and resolution of allergic airway inflammation. Clin Exp Allergy 2006; 36:111-21. [PMID: 16393273]
34. Simon HU. Cell death in allergic diseases. Apoptosis 2009; 14:439-46. [PMID: 19130232]
35. Helmberg A, Auphan N, Caelles C, Karin M. Glucocorticoidinduced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor. EMBO J 1995; 14:452-60. [PMID: 7859735]
36. Stahn C, Buttgereit F. Genomic and nongenomic effects of glucocorticoids. Nat Clin Pract Rheumatol 2008; 4:525-33. [PMID: 18762788]
37. Okada T, Ngo VN, Ekland EH, Forster R, Lipp M, Littman DR, Cyster JG. Chemokine requirements for B cell entry to lymph nodes and Peyer's patches. J Exp Med 2002; 196:65-75. [PMID: 12093871]
38. Curnow SJ, Wloka K, Faint JM, Amft N, Cheung CM, Savant V, Lord J, Akbar AN, Buckley CD, Murray PI, Salmon M. Topical glucocorticoid therapy directly induces up-regulation of functional CXCR4 on primed T lymphocytes in the aqueous humor of patients with uveitis. J Immunol 2004; 172:7154-61. [PMID: 15153539]
39. Nagase H, Miyamasu M, Yamaguchi M, Fujisawa T, Kawasaki H, Ohta K, Yamamoto K, Morita Y, Hirai K. Regulation of chemokine receptor expression in eosinophils. Int Arch Allergy Immunol 2001; 125:29-32. [PMID: 11408769]
40. Scannell M, Maderna P. Lipoxins and annexin-1: resolution of inflammation and regulation of phagocytosis of apoptotic cells. ScientificWorldJournal 2006; 6:1555-73. [PMID: 17160341]
41. Liu J, Zhu X, Myo S, Lambertino AT, Xu C, Boetticher E, Muñoz NM, Sano M, Cordoba M, Learoyd J, Meliton A, Johnson M, Leff AR. Glucocorticoid-induced surface expression of annexin 1 blocks beta2-integrin adhesion of human eosinophils to intercellular adhesion molecule 1 surrogate protein. J Allergy Clin Immunol 2005; 115:493-500. [PMID: 15753895]
42. Blanchard C, Rothenberg ME. Biology of the eosinophil. Adv Immunol 2009; 101:81-121. [PMID: 19231593]
43. Proksch JW, Lowe ER, Ward KW. Ocular pharmacokinetics of mapracorat, a novel selective glucocorticoid receptor agonist, in rabbits and monkeys. Drug Metab Dispos 2011; 39:1181-7. [PMID: 21441467]